Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 2101 - 2125 of 2342 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula ▲
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AP06
  • GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44260737 2081.175926 C98H176N4O42
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AX06
  • Fucalpha1-2Galbeta1-3GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44260801 2081.175926 C98H176N4O42
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AQ06
  • GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • type II A antigen(d18:1/26:0)
44261105 2081.175926 C98H176N4O42
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505BH06
  • GlcNAcbeta1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44261241 2081.175926 C98H176N4O42
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AP06
  • Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • I antigen(d18:1/26:0)
44261097 2097.170841 C98H176N4O43
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505BE06
  • Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44261217 2097.170841 C98H176N4O43
Simple Glc series LMSP0501AA00
  • GlcCer
  • Glcbeta-Cer
C01190 22801
Simple Glc series LMSP0501AB00
  • Galbeta1-4Glcbeta-Cer
  • LacCer
C01290 17950
Simple Glc series LMSP0501AC00
  • GalCer
  • Galbeta-Cer
C02686 18390
Simple Glc series LMSP0501AD00
  • Manbeta1-4Glcbeta-Cer
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AA00
  • Galalpha1-4Galbeta1-4Glcbeta-Cer
  • Gb3
GSG1328 18313
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AB00
  • GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer
  • Globoside I/Cytolipin K
GSG1154 18259
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC00
  • Forssman antigen
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer
GSG1161 18056
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AD00
  • GalNAcbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer
  • Para-Forssman x3b
GSG1338
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AE00
  • Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer
  • SSEA-3 antigen
GSG1197 62571
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AF00
  • Galbeta1-3(GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer
GSG1429
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AG00
  • Galbeta1-3(Galbeta1-4GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer
GSG1430
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AH00
  • Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-6(Galbeta1-3)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer
  • globo-Lex-9
GSG1272
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AI00
  • Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer
  • type IV H
GSG1360 62649
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AJ00
  • GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer
  • type IV A antigen
GSG1361
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AK00
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer
  • type IV B antigen
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AL00
  • Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer
GSG1194
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AM00
  • Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer
GSG1195
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AN00
  • Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer
GSG1196
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AO00
  • Galbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer
GSG1019

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024